WebMar 1, 2024 · HighLife SAS (Sponsor) Clinical Trials, 4 Results, Page 1. At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. WebNov 29, 2016 · HighLife SAS . Collaborator: MedPass International. Information provided by (Responsible Party): HighLife SAS. Study Details; Tabular View; No Results Posted ... Popolo Rubbio A, Mazzamuto M, Sgroi C, Lange R, Tamburino C. Transcatheter Mitral Valve Implantation Using the HighLife System. JACC Cardiovasc Interv. 2024 Aug …
HighLife SAS - Company Profile and News - Bloomberg Markets
WebDec 20, 2024 · HighLife SAS was established in 2010 and is headquartered in Paris, France, with offices in Irvine (California). It is focused on the development of a novel transeptal … WebOct 31, 2024 · HighLife SAS, an early-stage medtech company focused on the development of a unique trans-catheter mitral valve replacement (TMVR) system to treat patients suffering from mitral regurgitation, announced today the closing of a € 12.3 million investment round led by Sofinnova Partners which becomes the main investor in the … cypress creek mtb trail
Sorin Purchases Minority Share in Highlife SAS
WebDec 30, 2024 · The HighLife TSMVR system employs a unique "Valve-in-Ring" concept which can better cope with these challenges. This system separates the valve from its … WebMay 17, 2024 · Treatment. Official Title: HighLife TSMVR Feasibility Study of the Open Cell CLARITY Valve in Patients With Moderate-severe or Severe MR, High Surgical Risk and … WebOct 30, 2024 · About HighLife. HighLife SAS, headquartered in Paris, with offices in Irvine, Calif., is an early-stage company established in 2010. It is focused on the development of a novel transcatheter replacement system for treating mitral regurgitation. The technology aims at a beating heart procedure reducing trauma to the patients. binary code reading